BD PROJECTS

• Insights

  AbbVie boasts that it will become the largest CNS company in the industry next year!

  2025年8月2日
• Product for Licensing

  An asset similar to Roche’s trontinemab | DrugTimes BD Project

  2025年7月31日
• Product for Licensing

  DrugTimes BD Project DT-084 | A GLP-1/GCG/GIP Triagonist for the Treatment of Obesity, Type 2 Diabetes, and Steatohepatitis

  2025年7月31日
• Product for Licensing

  DrugTimes BD Project DTC-059 | Dual-Action FXl/FXla Inhibitor: A Low-Bleeding，Superior-Efficacy Antibody with Best-in-Class Potential

  2025年7月29日
• Pre-clinical

  A Preclinical Menin-MLL Inhibitor for Acute Myeloid Leukemia (AML) Seeking Partners

  2025年7月29日
• Product for Licensing

  DrugTimes BD Project | A Anti-C3 Nanobody Indicated for Geographic Atrophy

  2025年7月28日
• Product for Licensing

  Seeking Partners for a Bispecific Antibody Targeting IL4Rα/IL13 and IL31 for Atopic Dermatitis | DrugTimes BD Project

  2025年7月24日
• Request for Product

  Seeking Innovative Ophthalmology Drug Projects, Considering Small Molecules, Monoclonal/Polyclonal Antibodies, Nucleic Acid Drugs, Molecular Glues, Gene Therapies…

  2025年7月21日
• Request for Product

  Several Pharma Giants Vie for Next-Gen Obesity and Diabetes Therapies

  2025年7月18日
• Request for Product

  Global market opportunity! Buyers in urgent need of CNS-related products/platforms.

  2025年7月17日